SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Molina Healthcare, Inc. – ‘10-Q’ for 3/31/17 – ‘EX-10.3’

On:  Thursday, 5/4/17, at 4:23pm ET   ·   For:  3/31/17   ·   Accession #:  1179929-17-99   ·   File #:  1-31719

Previous ‘10-Q’:  ‘10-Q’ on 10/27/16 for 9/30/16   ·   Next:  ‘10-Q’ on 8/2/17 for 6/30/17   ·   Latest:  ‘10-Q’ on 4/25/24 for 3/31/24   ·   1 Reference:  By:  Molina Healthcare, Inc. – ‘10-K’ on 2/16/21 for 12/31/20

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 5/04/17  Molina Healthcare, Inc.           10-Q        3/31/17   79:11M

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    782K 
 2: EX-10.1     Material Contract                                   HTML     90K 
 3: EX-10.2     Material Contract                                   HTML     79K 
 4: EX-10.3     Material Contract                                   HTML     51K 
 5: EX-10.4     Material Contract                                   HTML     61K 
 6: EX-10.5     Material Contract                                   HTML     60K 
 7: EX-31.1     Certification -- §302 - SOA'02                      HTML     28K 
 8: EX-32.1     Certification -- §906 - SOA'02                      HTML     24K 
15: R1          Document and Entity Information                     HTML     43K 
16: R2          Consolidated Statements of Income                   HTML     81K 
17: R3          Consolidated Statements of Comprehensive Income     HTML     40K 
18: R4          Consolidated Balance Sheets                         HTML    136K 
19: R5          Consolidated Balance Sheets (Parenthetical)         HTML     38K 
20: R6          Consolidated Statements of Cash Flows               HTML    118K 
21: R7          Consolidated Statements of Cash Flows               HTML     25K 
                (Parenthetical)                                                  
22: R8          Basis of Presentation                               HTML     36K 
23: R9          Significant Accounting Policies                     HTML     80K 
24: R10         Net Income per Share                                HTML     45K 
25: R11         Fair Value Measurements                             HTML    122K 
26: R12         Investments                                         HTML    144K 
27: R13         Medical Claims and Benefits Payable                 HTML     68K 
28: R14         Debt                                                HTML     54K 
29: R15         Derivatives                                         HTML     51K 
30: R16         Stockholders' Equity                                HTML     53K 
31: R17         Segment Information                                 HTML     82K 
32: R18         Commitments and Contingencies                       HTML     45K 
33: R19         Related Party Transactions                          HTML     28K 
34: R20         Variable Interest Entities (VIEs)                   HTML     31K 
35: R21         Supplemental Condensed Consolidating Financial      HTML    529K 
                Information                                                      
36: R22         Significant Accounting Policies (Policies)          HTML     78K 
37: R23         Significant Accounting Policies (Tables)            HTML     56K 
38: R24         Net Income per Share (Tables)                       HTML     44K 
39: R25         Fair Value Measurements (Tables)                    HTML    117K 
40: R26         Investments (Tables)                                HTML    141K 
41: R27         Medical Claims and Benefits Payable (Tables)        HTML     61K 
42: R28         Debt (Tables)                                       HTML     46K 
43: R29         Derivatives (Tables)                                HTML     39K 
44: R30         Stockholders' Equity (Tables)                       HTML     40K 
45: R31         Segment Information (Tables)                        HTML     77K 
46: R32         Supplemental Condensed Consolidating Financial      HTML    531K 
                Information (Tables)                                             
47: R33         Basis of Presentation (Details)                     HTML     43K 
48: R34         Significant Accounting Policies - Additional        HTML     43K 
                Information (Details)                                            
49: R35         Significant Accounting Policies - 3R Program        HTML     46K 
                Receivables (Payables) (Details)                                 
50: R36         Significant Accounting Policies - Quality           HTML     39K 
                Incentive Premium Revenue Recognized (Details)                   
51: R37         Net Income per Share (Detail)                       HTML     58K 
52: R38         Fair Value Measurements - Fair Value of Financial   HTML     98K 
                Instruments on Recurring Basis (Details)                         
53: R39         Fair Value Measurements - Details of Long-Term      HTML     52K 
                Debt (Details)                                                   
54: R40         Investments - Summary of Investments (Details)      HTML     52K 
55: R41         Investments - Contractual Maturities of             HTML     48K 
                Investments (Details)                                            
56: R42         Investments - Available-for-Sale Investments        HTML     52K 
                (Details)                                                        
57: R43         Investments - Held to Maturity Investments          HTML     41K 
                (Details)                                                        
58: R44         Medical Claims and Benefits Payable - Medical       HTML     33K 
                Claims and Future Benefits (Details)                             
59: R45         Medical Claims and Benefits Payable - Components    HTML     53K 
                of Change in Medical Claims and Benefits Payable                 
                (Details)                                                        
60: R46         Medical Claims and Benefits Payable - Additional    HTML     32K 
                Information (Details)                                            
61: R47         Debt - Schedule of Long-Term Debt (Details)         HTML     64K 
62: R48         Debt - Additional Information(Details)              HTML     70K 
63: R49         Derivatives (Details)                               HTML     47K 
64: R50         Stockholders' Equity - Additional Information       HTML     58K 
                (Details)                                                        
65: R51         Stockholders' Equity - Share Activity (Details)     HTML     54K 
66: R52         Segment Information - Additional Information        HTML     23K 
                (Details)                                                        
67: R53         Segment Information - Schedule of Operating         HTML     38K 
                Segment Information (Details)                                    
68: R54         Segment Information - Reconciliation of Gross       HTML     50K 
                Margin to Consolidated Income (Details)                          
69: R55         Commitments and Contingencies (Details)             HTML     79K 
70: R56         Related Party Transactions (Details)                HTML     25K 
71: R57         Variable Interest Entities (VIEs) (Details)         HTML     34K 
72: R58         Supplemental Condensed Consolidating Financial      HTML     27K 
                Information - Additional Information (Details)                   
73: R59         Supplemental Condensed Consolidating Financial      HTML     92K 
                Information - Statements of Income (Details)                     
74: R60         Supplemental Condensed Consolidating Financial      HTML     45K 
                Information - Comprehensive Income (Details)                     
75: R61         Supplemental Condensed Consolidating Financial      HTML    185K 
                Information - Balance Sheet (Details)                            
76: R62         Supplemental Condensed Consolidating Financial      HTML    104K 
                Information - Cash Flows (Details)                               
78: XML         IDEA XML File -- Filing Summary                      XML    136K 
77: EXCEL       IDEA Workbook of Financial Reports                  XLSX     90K 
 9: EX-101.INS  XBRL Instance -- moh-20170331                        XML   3.59M 
11: EX-101.CAL  XBRL Calculations -- moh-20170331_cal                XML    260K 
12: EX-101.DEF  XBRL Definitions -- moh-20170331_def                 XML    728K 
13: EX-101.LAB  XBRL Labels -- moh-20170331_lab                      XML   1.50M 
14: EX-101.PRE  XBRL Presentations -- moh-20170331_pre               XML   1.02M 
10: EX-101.SCH  XBRL Schema -- moh-20170331                          XSD    164K 
79: ZIP         XBRL Zipped Folder -- 0001179929-17-000099-xbrl      Zip    264K 


‘EX-10.3’   —   Material Contract


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Exhibit  
Exhibit 10.3

Molina Healthcare, Inc. 2011 Equity Incentive Plan
Restricted Stock Award Agreement


This RESTRICTED STOCK AWARD AGREEMENT (the “Agreement”) effective as of _________, _____ is between Molina Healthcare, Inc., a Delaware corporation (the “Company”), and __________________, an employee of the Company or one of its Affiliates (the “Grantee”), pursuant to and subject to the terms and conditions of the Molina Healthcare, Inc. 2011 Equity Incentive Plan (the “Plan”). The Company desires to award to the Grantee a number of shares of the Company’s common stock, par value $.001 per share (the “Common Stock”), subject to certain restrictions as provided in this Agreement, in order to carry out the purpose of the Plan. The purpose of this Agreement is to evidence the terms and conditions of an award of restricted stock granted to the Grantee under the Plan.

Accordingly, for good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Company and the Grantee hereby agree as follows:

Section 1. Award of Restricted Stock.

Effective as of ________, _____ (the “Effective Date”), the Company grants to the Grantee a restricted stock award of ____________ shares of Common Stock (the “Shares”), subject to the terms and conditions set forth in this Agreement and in accordance with the terms of the Plan (the “Restricted Stock Award”).

Section 2. Rights with Respect to the Shares.

(a)    Stockholder Rights. With respect to the Shares, the Grantee shall be entitled at all times on and after the date of issuance of the Shares to exercise the rights of a stockholder of Common Stock of the Company, including the right to vote the Shares and the right to receive dividends on the Shares as provided in Section 2(b) hereof, unless and until the Shares are forfeited pursuant to Section 3 hereof. However, the Shares shall be nontransferable and subject to a risk of forfeiture to the Company at all times prior to the dates on which such Shares become vested, and the restrictions with respect to the Shares lapse, in accordance with Section 3 of this Agreement.

(b)    Dividends. As a condition to receiving the Shares under the Plan, the Grantee hereby agrees to defer the receipt of dividends paid on the Shares. Cash dividends or other cash distributions paid with respect to the Shares prior to the date or dates the Shares vest shall be subject to the same restrictions, terms, and conditions as the Shares to which they relate, shall be promptly deposited with the Secretary of the Company or a custodian designated by the Secretary, and shall be forfeited in the event that the Shares with respect to which the dividends were paid are forfeited.

(c)    Issuance of Shares. The Company shall cause the Shares to be issued in the Grantee’s name or in a nominee name on the Grantee’s behalf, either by book-entry registration or issuance of a stock certificate or certificates evidencing the Shares, which certificate or certificates shall be held by the Secretary of the Company or the stock transfer agent or brokerage service selected by the Secretary of the Company to provide such services for the Plan. The Shares shall be restricted from transfer and shall be subject to an appropriate stop-transfer order. If any certificate is issued, the certificate shall bear an appropriate legend referring to the restrictions applicable to the Shares. The Grantee hereby agrees to the retention by the Company of the Shares and, if a stock certificate is issued, the Grantee agrees to execute and deliver to the Company a blank stock power with respect to the Shares as a condition to the receipt of this Restricted Stock Award. After any Shares vest pursuant to Section 3 hereof, and following payment of the applicable withholding taxes pursuant to Section 6 of this Agreement, the Company shall promptly cause to be issued a certificate or certificates, registered in the Grantee’s name, evidencing such vested whole Shares (less any Shares withheld to pay withholding taxes) and shall cause such certificate or certificates to be delivered to

    



the Grantee free of the legend and the stop-transfer order referenced above. The Company will not deliver any fractional Share but will pay, in lieu thereof, the Fair Market Value of such fractional Share at the time certificates evidencing the Shares are delivered to the Grantee.

Section 3. Vesting; Forfeiture.

(a)    Vesting. Subject to the terms and conditions of this Agreement, one-fourth (1/4th) of the Shares shall vest, and the restrictions with respect to the Shares shall lapse, on each of the first, second, third, and fourth anniversaries of the Effective Date if the Grantee remains continuously employed by the Company or an Affiliate of the Company until such respective vesting dates.

(b)    Forfeiture. If the Grantee ceases to be employed by the Company and all Affiliates of the Company for any reason prior to the vesting of the Shares pursuant to Section 3(a) hereof, Grantee’s rights to all of the unvested Shares shall be immediately and irrevocably forfeited, including the right to vote such Shares and the right to receive dividends on such Shares.

(c)No Early Vesting. Unless otherwise determined by the Committee in its sole discretion, in no event will any of the Shares vest prior to their respective vesting dates set forth in Section 3(a) hereof.

Section 4. Restrictions on Transfer.

Until the Shares vest pursuant to Section 3 hereof, neither the Shares, nor any right with respect to the Shares under this Agreement, may be sold, assigned, transferred, pledged, hypothecated (by operation of law or otherwise) or otherwise conveyed or encumbered and shall not be subject to execution, attachment or similar process. Any attempted sale, assignment, transfer, pledge, hypothecation or other conveyance or encumbrance shall be void and unenforceable against the Company or any Affiliate of the Company.

Section 5. Distributions and Adjustments.

(a)    If any Shares vest subsequent to any change in the number or character of the Common Stock of the Company through any stock dividend or other distribution, recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase or exchange of shares or other securities of the Company, issuance of warrants or other rights to purchase shares of Common Stock or other securities of the Company or other similar corporate transaction or event such that an adjustment is determined by the Committee to be appropriate in order to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under this Agreement, then the Committee shall, in such manner as it may deem equitable, in its sole discretion, adjust any or all of the number and type of such Shares.

(b)Any additional shares of Common Stock of the Company, any other securities of the Company and any other property distributed with respect to the Shares prior to the date or dates the Shares vest shall be subject to the same restrictions, terms and conditions as the Shares to which they relate and shall be promptly deposited with the Secretary of the Company or a custodian designated by the Secretary.

Section 6. Taxes.

(a)    The Grantee acknowledges that the Grantee will consult with the Grantee’s personal tax adviser regarding the income tax consequences of the grant of the Shares, payment of dividends on the Shares, the vesting of the Shares and any other matters related to this Agreement. In order to comply with all applicable federal, state, local or foreign income tax laws or regulations, the Company may take such action as it deems appropriate to ensure that all applicable federal, state, local or foreign payroll, withholding, income or other taxes, which are the Grantee’s sole and absolute responsibility, are withheld or collected from the Grantee.

2





(b)In accordance with the terms of the Plan, and such rules as may be adopted by the Committee administering the Plan, the Grantee may elect to satisfy tax withholding obligations arising from the receipt of, or the lapse of restrictions relating to, the Shares by (i) delivering cash, check, bank draft, money order or wire transfer payable to the order of the Company, (ii) having the Company withhold a portion of the Shares otherwise to be delivered having a Fair Market Value equal to the amount of such taxes, or (iii) delivering to the Company shares of Common Stock having a Fair Market Value equal to the amount of such taxes. The Company will not deliver any fractional Share but will pay, in lieu thereof, the Fair Market Value of such fractional Share. The Grantee’s election must be made on or before the date that the amount of tax to be withheld is determined. If the Grantee does not make an election, the Company will withhold a portion of the Shares otherwise to be delivered having a Fair Market Value equal to the amount of such taxes.

Section 7. Non-Solicitation.

The Grantee acknowledges and agrees that during the period of Grantee’s employment by the Company (or any Subsidiary), and for a period of one (1) year after termination of Grantee’s Service Relationship for any reason, with or without Cause, Grantee shall not directly or indirectly, either alone or in concert with others, solicit, entice, or encourage the hiring of any employee of the Company (or any Subsidiary) unless such person was involuntarily terminated or laid off by the Company (or any Subsidiary).

Section 8. Confidentiality.

The Grantee agrees to keep and maintain in strict confidence all confidential and proprietary information of the Company (or any Subsidiary) during and after the term of employment by the Company, and to never directly or indirectly make known, divulge, reveal, furnish, make available, or use any confidential information (except in the course of regular authorized duties on behalf of the Company or any Subsidiary). Grantee’s obligations of confidentiality hereunder shall survive termination of employment regardless of any actual or alleged breach by the Company (or any Subsidiary) in connection with such termination, until and unless any such confidential information shall have become, through no fault of Grantee, generally known to the public or unless Grantee is required by law to make disclosure (after giving the Company or any Subsidiary notice and an opportunity to contest such requirement). Grantee’s obligations under this Section are in addition to and not in limitation or preemption of all other obligations of confidentiality which Grantee has to the Company under general legal or equitable principles. All documents and other property including or reflecting confidential information furnished to Grantee by the Company or otherwise acquired or developed by the Company shall at all times be the property of the Company (or any Subsidiary). Upon termination of employment, Grantee shall return to the Company (or any Subsidiary) any such documents or other property (including copies, summaries, or analyses of the foregoing) of the Company (or any Subsidiary) which are in Grantee’s possession, custody, or control.

Section 9. Definitions.

Terms not defined in this Agreement shall have the meanings given to them in the Plan.

Section 10. Governing Law.

The internal law, and not the law of conflicts, of the State of California will govern all questions concerning the validity, construction and effect of this Agreement.

Section 11. Plan Provisions.

This Agreement is made under and subject to the provisions of the Plan, and all of the provisions of the Plan are also provisions of this Agreement. If there is a difference or conflict between the provisions of this Agreement and the provisions of the Plan, the provisions of the Plan will govern. By accepting this

3




Restricted Stock Award, the Grantee confirms that the Grantee has received a copy of the Plan and represents that the Grantee is familiar with the terms and provisions thereof, and hereby accepts this Restricted Stock Award subject to all the terms and provisions of the Plan.

Section 12. No Rights to Continue Service or Employment.

Nothing herein shall be construed as giving the Grantee the right to continue in the employ or to provide services to the Company or any Affiliate, whether as an employee or as a consultant or otherwise, or interfere with or restrict in any way the right of the Company or any Affiliate to discharge the Grantee, whether as an employee or consultant or otherwise, at any time, with or without cause. In addition, the Company or any Affiliate may discharge the Grantee free from any liability or claim under this Agreement.

Section 13. Entire Agreement.

This Agreement together with the Plan supersede any and all other prior understandings and agreements, either oral or in writing, between the parties with respect to the subject matter hereof and constitute the sole and only agreements between the parties with respect to said subject matter. All prior negotiations and agreements between the parties with respect to the subject matter hereof are merged into this Agreement. Each party to this Agreement acknowledges that no representations, inducements, promises or agreements, orally or otherwise, have been made by any party or by anyone acting on behalf of any party, which are not embodied in this Agreement or the Plan and that any agreement, statement or promise that is not contained in this Agreement or the Plan shall not be valid or binding or of any force or effect.

Section 14. Modification.

No change or modification of this Agreement shall be valid or binding upon the parties unless the change or modification is in writing and signed by the parties. Notwithstanding the preceding sentence, the Plan, this Agreement and the Restricted Stock Award may be amended, altered, suspended, discontinued or terminated to the extent permitted by the Plan.

Section 15. Shares Subject to Agreement.

The Shares shall be subject to the terms and conditions of this Agreement. Except as otherwise provided in Section 5, no adjustment shall be made for dividends or other rights for which the record date is prior to the issuance of the Shares. The Company shall not be required to deliver any Shares until the requirements of any federal or state securities or other laws, rules or regulations (including the rules of any securities exchange) as may be determined by the Committee to be applicable are satisfied.

Section 16. Severability.

In the event that any provision that is contained in the Plan or this Agreement is or becomes or is deemed to be invalid, illegal or unenforceable in any jurisdiction or would disqualify the Plan or this Agreement for any reason and under any law as deemed applicable by the Committee, the invalid, illegal or unenforceable provision shall be construed or deemed amended to conform to applicable laws, or if it cannot be so construed or deemed amended without, in the determination of the Committee, materially altering the purpose or intent of the Plan or this Agreement, such provision shall be stricken as to such jurisdiction or Shares, and the remainder of the Plan or this Agreement shall remain in full force and effect.


4




Section 17. Headings.

Headings are given to the sections and subsections of this Agreement solely as a convenience to facilitate reference. Such headings shall not be deemed in any way material or relevant to the construction or interpretation of this Agreement or any provision hereof.

Section 18. Grantee’s Acknowledgments.

The Grantee hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Committee or the Board of Directors of the Company, as appropriate, upon any questions arising under the Plan or this Agreement. Any determination in this connection by the Company, including the Board of Directors of the Company or the Committee, shall be final, binding and conclusive. The obligations of the Company and the rights of the Grantee are subject to all applicable laws, rules and regulations.

Section 19. Parties Bound.

The terms, provisions and agreements that are contained in this Agreement shall apply to, be binding upon, and inure to the benefit of the parties and their respective heirs, executors, administrators, legal representatives and permitted successors and assigns, subject to the limitation on assignment expressly set forth herein. This Agreement shall have no force or effect unless it is duly executed and delivered by the Company.

Section 20. Counterparts.

This Agreement may be executed in counterparts, each of which shall constitute an original, but both of which when taken together shall constitute a single contract. Delivery of an executed counterpart of a signature page of this Agreement by telecopy shall be effective as delivery of a manually executed counterpart of this Agreement.

IN WITNESS WHEREOF, each of the parties has executed this Agreement, in the case of the Company by its duly authorized officer, effective as of the day and year first above written.

MOLINA HEALTHCARE, INC.
 
 
 
 
 
 
By:
 
 
 
 
[Name]
 
 
 
 
 
 
Its:
[Title]
 
 





5


1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/16/21  Molina Healthcare, Inc.           10-K       12/31/20  122:15M
Top
Filing Submission 0001179929-17-000099   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., May 4, 11:24:29.1am ET